Clinical Trial Update: Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating TCMCB07 to safely optimize body weight in patients with newly diagnosed metastatic colorectal cancer undergoing chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TCMCB07 (TCMCB07)

Snippet

Sponsor: Endevica Bio | Conditions: Cancer Weight Loss | Phase 2 | Status: RECRUITING